A carregar...
Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial
BACKGROUND: The combination of ribavirin (RBV) and pegylated interferon (PEG-IFN) is effective in the treatment of chronic hepatitis C infection. Reducing the frequency of RBV intake from twice to once a day will improve compliance and opens up the opportunity to combine RBV with new and more specif...
Na minha lista:
| Publicado no: | Pharmgenomics Pers Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4593207/ https://ncbi.nlm.nih.gov/pubmed/26445557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S82782 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|